Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Leukoencephalopathy with vanishing white matter (VWM; MONDO:0800448) is an autosomal recessive leukodystrophy characterized by stress-provoked episodes of rapid neurological decline and chronic white matter rarefaction (PMID:15670229). EIF2B3 (HGNC:3259) encodes the γ-subunit of the eukaryotic translation initiation factor eIF2B, and pathogenic biallelic variants disrupt guanine nucleotide exchange factor (GEF) activity, leading to impaired protein synthesis under stress and progressive demyelination (PMID:11835386).
Initial case reports identified compound heterozygous missense variants in adult-onset VWM, including c.260C>T (p.Ala87Val) and c.272G>A (p.Arg91His) in a 29-year-old woman presenting with confusion, headaches, and ovarian failure (PMID:22312164). Subsequent adult cases confirmed c.260C>T (p.Ala87Val) in differential diagnosis of primary progressive multiple sclerosis (PMID:25135182). Prenatal onset with homozygous c.97A>G (p.Lys33Glu) in two siblings highlighted early manifestations and segregation in consanguineous families (PMID:28597716).
A multi-center study of 341 patients across 87 reports identified over 180 distinct EIF2B3 mutations, predominantly missense (86%) with occasional nonsense and frameshift changes, reinforcing autosomal recessive inheritance and extensive allelic heterogeneity (PMID:34745209). Founder effects such as the c.260C>T (p.Ala87Val) allele in Quebec were noted in French-Canadian patients, with recurrent homozygosity in three unrelated individuals (PMID:25079571).
Functional assays demonstrate variable effects on eIF2B complex integrity and GEF activity: several patient-derived and recombinant complexes show reduced activity under stress, correlating imperfectly with clinical severity (PMID:21560189, PMID:26285592). An eif2b3-null zebrafish model recapitulates myelin defects, glial dysregulation, and ectopic angiogenesis, validating novel alleles including c.503T>C (p.Leu168Pro) (PMID:33517449). iPSC-derived cerebral organoids from EIF2B3 mutants exhibit unfolded protein response activation, delayed neuronal differentiation, and oligodendrocyte paucity (PMID:36650674).
No studies to date have refuted the EIF2B3–VWM link; rather, disparate models and broad phenotypic spectra from antenatal to adult onset converge on a loss-of-function mechanism. The robust genetic and functional data fulfill ClinGen criteria for a Definitive gene-disease relationship.
Key Take-home: Genetic testing of EIF2B3 is critical for early diagnosis of VWM across age ranges; variant identification guides prognosis, family planning, and supports emerging therapeutic trials targeting eIF2B downstream pathways.
Gene–Disease AssociationDefinitiveMultiple unrelated patients (>341 probands), consistent autosomal recessive inheritance, functional concordance Genetic EvidenceStrong341 probands with biallelic EIF2B3 variants and >180 distinct mutations across cohorts ([PMID:34745209]) Functional EvidenceStrongBiochemical assays, zebrafish knockout, and iPSC organoid models recapitulate disease mechanism |